Last reviewed · How we verify

NCT07108400

Efficacy of a Combination of Ultrasound-guided Intra-articular Injections of Hyaluronic Acid, High-power Laser Therapy and Rehabilitation on Functioning in Patients Affected by Hip Osteoarthritis.

Recruiting now NA Last updated 7 August 2025
What this trial tests

NA trial testing ultrasound-guided injections of hyaluronic acid plus high-power laser therapy in Hip Osteoarthritis in 57 participants. Currently enrolling.

Timeline
17 March 2022
Primary endpoint
3 August 2025
12 December 2025

Quick facts

Lead sponsorDe Sire Alessandro
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment57
Start date17 March 2022
Primary completion3 August 2025
Estimated completion12 December 2025
Sites2 locations across Italy

Drugs / interventions tested

Conditions studied

Sponsor

De Sire Alessandro

Who can join

Adults 18 to 85, any sex, with Hip Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

High-power laser therapy (HPLT) is effective in treating musculoskeletal conditions, reducing pain and improving joint functionality. This randomized controlled trial (RCT) aimed to explore the effectiveness of a combination of HPLT, hyaluronic acid injections, and rehabilitation for patients with hip osteoarthritis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Combined ultrasound-guided hyaluronic acid injections, high-power laser therapy and physiotherapy improve hip function in osteoarthritis: A randomized controlled trial.
    de Sire A, Marotta N, Bartalotta I, Prestifilippo E, et al · · 2026 · PMID 42255387 · DOI 10.1002/jeo2.70685

Verify or expand the search:

Other recruiting trials for Hip Osteoarthritis

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07108400.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing